是时候摒弃膀胱癌研究中的“表面化”现象了。 - Suppr

It is time to abandon the "superficial" in bladder cancer.

作者信息

Soloway Mark S

出版信息

Eur Urol. 2007 Dec;52(6):1564-5. doi: 10.1016/j.eururo.2007.07.011. Epub 2007 Jul 17.

DOI:10.1016/j.eururo.2007.07.011

PMID:17681680

Abstract

摘要

相似文献

It is time to abandon the "superficial" in bladder cancer.

Eur Urol. 2007 Dec;52(6):1564-5. doi: 10.1016/j.eururo.2007.07.011. Epub 2007 Jul 17.

Eliminate the term "superficial" bladder cancer.

J Urol. 2006 Feb;175(2):417-8. doi: 10.1016/S0022-5347(05)00290-9.

["Superficial bladder cancers" do not exist anymore].

Prog Urol. 2008 Apr;18(4):204-5. doi: 10.1016/j.purol.2008.03.002. Epub 2008 May 2.

Have we abandoned the "superficial" in bladder cancer?

Eur Urol. 2009 Dec;56(6):1091. doi: 10.1016/j.eururo.2009.03.051. Epub 2009 Mar 31.

The term 'superficial bladder cancer' should be abandoned.

Eur Urol. 2000 Nov;38(5):597-9. doi: 10.1159/000020337.

Lymph node assessment and lymphadenectomy in bladder cancer.

J Surg Oncol. 2009 Mar 15;99(4):225-31. doi: 10.1002/jso.21253.

Superficial bladder cancer metastatic to the lungs: two case reports and review of the literature.

Urology. 2009 Jan;73(1):210.e3-5. doi: 10.1016/j.urology.2008.01.050. Epub 2008 Apr 18.

Molecular alterations associated with bladder cancer initiation and progression.

Scand J Urol Nephrol Suppl. 2008 Sep(218):154-65. doi: 10.1080/03008880802291915.

A critical appraisal of the classification of urothelial tumours: time for a change, but not the change proposed.

BJU Int. 2007 Dec;100(6):1213-4; discussion 1214-5. doi: 10.1111/j.1464-410X.2007.07178.x. Epub 2007 Aug 17.

[Clinical value of aneusomy of chromosomes in exfoliated urothelial cells to predict the recurrence of superficial bladder cancer after complete transurethral resection].

Zhonghua Yi Xue Za Zhi. 2009 Mar 3;89(8):548-51.

引用本文的文献

A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E.

Bladder Cancer. 2022 Dec 14;8(4):379-393. doi: 10.3233/BLC-220026. eCollection 2022.

Is cystoscopy follow-up protocol safe for low-risk bladder cancer without muscle invasion?

Urol Ann. 2020 Jan-Mar;12(1):25-30. doi: 10.4103/UA.UA_143_18. Epub 2019 Nov 7.

Heated Intravesical Chemotherapy: Biology and Clinical Utility.

Urol Clin North Am. 2020 Feb;47(1):55-72. doi: 10.1016/j.ucl.2019.09.008.

Bladder preservation approach versus radical cystectomy for high-grade non-muscle-invasive bladder cancer: a meta-analysis of cohort studies.

World J Surg Oncol. 2018 Oct 2;16(1):197. doi: 10.1186/s12957-018-1497-0.

p53 status correlates with the risk of progression in stage T1 bladder cancer: a meta-analysis.

World J Surg Oncol. 2016 Apr 30;14:137. doi: 10.1186/s12957-016-0890-9.

Bladder cancer: Active surveillance for low-grade Ta bladder tumours.

Nat Rev Urol. 2016 Jun;13(6):303-4. doi: 10.1038/nrurol.2016.35. Epub 2016 Feb 16.

Human epidermal growth factor receptor 2: a significant indicator for predicting progression in non-muscle-invasive bladder cancer especially in high-risk groups.

World J Urol. 2015 Dec;33(12):1951-7. doi: 10.1007/s00345-015-1557-9. Epub 2015 Apr 18.

Snail is an independent prognostic indicator for predicting recurrence and progression in non-muscle-invasive bladder cancer.

Int Urol Nephrol. 2015 Feb;47(2):289-93. doi: 10.1007/s11255-014-0874-z. Epub 2014 Nov 12.

[C-reactive protein prior to radical cystectomy: preoperative determination of CRP].

Urologe A. 2014 Feb;53(2):222-7. doi: 10.1007/s00120-013-3299-x.

The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer.

PLoS One. 2012;7(10):e47199. doi: 10.1371/journal.pone.0047199. Epub 2012 Oct 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

It is time to abandon the "superficial" in bladder cancer.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献